Epidemiological burden of schistosomiasis among schoolchildren in conflict-stricken mesoendemic districts of Yemen: A decade after national mapping
Open Access
- 11 November 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 19 (11) , e0013723
Abstract
Background: Despite multiple rounds of mass drug administration (MDA), schistosomiasis remains a major public health problem in Yemen. This study assessed the burden of schistosomiasis among schoolchildren in mesoendemic districts over a decade after the 2014 national mapping in the context of the ongoing humanitarian crisis, conflict, and disrupted control efforts. Methods: A cross-sectional study was conducted among 348 schoolchildren aged 5–15 years in three randomly selected mesoendemic districts: Al Husha, Bura, and Habur Zulaymah districts. Data on sociodemographics and potential risk factors were collected using a pilot-tested, structured questionnaire. Parasitological examinations for Schistosoma haematobium and S. mansoni were performed using urine filtration and Kato-Katz techniques, respectively. Independent predictors of infection were identified using multivariable binary logistic regression. Results: The overall schistosomiasis prevalence among schoolchildren was 21% (95% CI: 17, 25), with 13.5% infected with S. haematobium , 6% with S. mansoni , and 1.4% co-infected. Compared to 2014, prevalence increased across all study districts, particularly for S. haematobium . Most infections were of light intensity. Infection with S. haematobium was significantly associated with dysuria, macrohematuria, microhematuria, and proteinuria. Independent predictors of schistosomiasis included male gender (AOR = 2.6; 95% CI: 1.34, 4.82; P = 0.003), age ≥ 10 years (AOR = 2.4; 95% CI: 1.20, 4.92; P = 0.013), household size larger than eight members (AOR = 2.4; 95% CI: 1.28, 4.63; P = 0.007), and contact with open water sources (AOR = 2.5; 95% CI: 1.20, 5.19; P = 0.014). Conclusion: Despite multiple MDA campaigns, schistosomiasis remains moderately endemic in the districts of Yemen classified as mesoendemic in 2014, with an increased S. haematobium prevalence. While MDA has reduced the prevalence of heavy infections, transmission persists. These findings underscore the need for an integrated strategy combining biannual MDA, health education, improved sanitation, and environmental management to interrupt transmission.Keywords
This publication has 30 references indexed in Scilit:
- Prevalence and Reinfection Rates of Schistosoma mansoni and Praziquantel Efficacy against the Parasite among Primary School Children in Sanja Town, Northwest EthiopiaJournal of Parasitology Research, 2019
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2018
- Mass Drug Administration (MDA) for SchistosomiasisThe Journal of Infectious Diseases, 2014
- Urinary schistosomiasis among schoolchildren in YemenJournal of the Egyptian Public Health Association, 2013
- Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patternsActa Tropica, 2013
- Towards nationwide control of schistosomiasis in Yemen: a pilot project to expand treatment to the whole communityTransactions of the Royal Society of Tropical Medicine and Hygiene, 2011
- Prevalence and co-infections of schistosomiasis/hepatitis B and C viruses among school children in an endemic areas in Taiz, YemenAsian Pacific Journal of Tropical Medicine, 2011
- Human schistosomiasisThe Lancet, 2006
- Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasisThe Lancet, 2005
- Reinfection with Schistosoma haematobium following school‐based chemotherapy with praziquantel in four highly endemic villages in Côte d’IvoireTropical Medicine & International Health, 2001